Reliance Industries' offer to buy Walgreens' international stores. Motley Fool analyst Deidre Woollard and Motley Fool contributor Demitri Kalogeropoulos serve up three stocks and explain how the companies behind them are shaping the future of food. To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center.
SANDUSKY, Mich., April 23, 2024--Highline Michigan Announces Three New Smart Rural Communities
BOSTON, April 23, 2024--Advent Technologies Holdings, Inc. (Nasdaq: ADN) announced today that, as expected, it received a notice from Nasdaq on April 17, 2024, notifying the Company that it is not in compliance with the periodic filing requirements for continued listing set forth in Nasdaq Listing Rule 5250(c)(1) because the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 ("Fiscal Year 2023 10-K") was not filed with the Securities and Exchange Commission (the "SEC") by
Visa (V) reported better-than-expected second quarter results. Adjusted earnings per share of $2.51 topped estimates of $2.09. Net revenue was $8.78 billion compared to an expectation of $8.62 billion. Yahoo Finance's Julie Hyman and Jared Blikre break down the report. For more expert insight and the latest market action, click here to watch this full episode. This post was written by Stephanie Mikulich.
Victoria Lee Robinson first appeared on Tom Sandoval’s Instagram in February 2024
Philipps also revealed she was Jerry Ferrara's first "make out" partner on the show
Just as our working lives have different phases, from early in your career to raises and promotions that ideally enable you to buy a house and start a family, retirement also has phases of increased...
With mating season kicking off in the Sunshine State, one 10-foot gator apparently went looking for love between the tires of an aerial refueling aircraft.
The US Food and Drug Administration has approved ImmunityBio's (IBRX) bladder cancer therapy, a significant milestone for the company. ImmunityBio Executive Chairman Dr. Patrick Soon-Shiong, joins Market Domination alongside Yahoo Finance's health reporter Anjalee Khemlani to discuss the company's plans following this pivotal approval. Soon-Shiong says that Anktiva will be "the next generation of immuno-therapy." He claims the drug is the first of its kind to "generate complete remission that's completely durable" for 47 months and longer. Soon-Shiong believes the drug will serve as "a backbone" to "checkpoint inhibitors," a class of immunotherapy drugs. He envisions the drug's potential to target cancers regardless of their location within the body, describing it as "an opportunity to use this as a fundamental platform across all tumor types." Soon-Shiong says he, alongside other entities, collectively invested around $400 million in the company when the drug was first rejected. He further notes that additional investments totaling $100 million are forthcoming, stating, "the company is stable in terms of cash capabilities,"— hoping for a commercial launch of Anktiva in May. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Angel Smith
GE Aerospace (GE) shares are trading higher in Tuesday's afternoon session after the company surpassed analyst estimates on both revenue and earnings in its first quarterly report since becoming a standalone entity following General Electric's split into three separate companies. The company's better-than-expected performance, coupled with an upward revision of its 2024 profit guidance, has boosted investor confidence in the stock. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Angel Smith
Elias Huizar has taken baby boy and fled for the US-Mexico border, police say
Tesla earnings tumbled below lowered expectations. Tesla stock jumped late as the EV giant signaled an affordable EV is still it its plans. Elon Musk looms.
The left wrist injury Jordan Spieth first suffered a week before the PGA Championship last year hasn’t gone away. “It’s a come-and-go thing,” Spieth said last week after his pro-am round at the RBC Heritage. Spieth said the tendon sheath is torn enough that it won’t hold the tendon perfectly in place.
The couple is parents to daughters Alexia, 24, Stella, 13, Gia, 14, and Isabella, 16
Major indexes rose on Tuesday as Tesla, Microsoft, Meta and Google parent Alphabet head into earnings. Friday's inflation report for March is on watch.
Do the markets bow to Big Tech or are tech leaders influenced by broader market trends? Big Tech weighs heavily on the stock market (^DJI, ^IXIC, ^GSPC) this earnings season after the run-ups — and eventual declines — in stocks comprising the Magnificent Seven. Yahoo Finance's Head of News Myles Udland and Markets Reporter Josh Schafer join Market Domination Overtime to talk about earnings forecasts for dominant tech companies like Nvidia (NVDA) and where the biggest catalysts lie this earnings season. For more expert insight and the latest market action, click here to watch this full episode of Market Domination Overtime. This post was written by Luke Carberry Mogan.
Texas Instruments beat Wall Street's targets for the first quarter and guided above views for sales and in line for earnings for Q2.
Pitbull is hitting the road once again on the upcoming Party After Dark Tour. T-Pain will join as special guest. See dates and how to get tickets.
Father ‘saw his little daughter die before his eyes’ says charity worker after Channel rescue
"I haven’t quite thought about it completely," Dunne said about her possible return to LSU.
The IIF banking trade group said flows were positive for both bonds and equities last month, with equities absorbing $10.2 billion and debt $22.5 billion. The data showed it was the first time since September 2021 that China and ex China, bonds and equities, posted simultaneous monthly inflows. China stocks took in $1.7 billion and bonds $2.1 billion.
Yahoo Finance